VANCOUVER, B.C., Nov. 6, 2014 (GLOBE NEWSWIRE) -- via PRWEB - According to a report series by iData Research (http://www.idataresearch.com), diode lasers in the U.S. are anticipated to sell almost double the number of units in 2020 as compared to 2014, which is a difference of more than 6,000 sales, boosting the 2020 installed base to more than 90,000. The dental laser markets for Europe and the United States were collectively worth more than USD 139 million in 2014.
"Diode lasers remain the most popular option for dental offices due to their affordable pricing," explains Dr. Kamran Zamanian of iData. "They are often purchased at a fraction of the cost of the next most affordable dental laser type. This has enabled diode lasers to penetrate the market much more quickly compared to other laser types."
The dental laser market is best divided into diode, CO2, Nd:YAG, articulated arm, fiber-delivered, and direct delivery laser types. In the U.S., CO2 lasers were the first laser type to be introduced to the dental industry for use on soft tissue. However, since the introduction of more affordable diode lasers, the market for CO2 lasers has declined significantly. Sales of Nd:YAG lasers remained fairly consistent in 2014. The all tissue dental lasers market, which includes the fiber-delivered and articulated arm segments, will see a low compound annual growth rate of just over 3% by 2020. Direct delivery dental lasers do not as of yet have a significant presence in the United States.
In Europe, Light Instruments Ltd. expects their LiteTouch direct delivery laser to drive sales in the direct delivery laser market segment. The pricing and novelty of all tissue lasers discourage dentists from making an investment unless a high-end clinic is owned. As a whole, the European all tissue laser market is not expected to see significant gains until after 2020.
The soft tissue dental laser market in Europe, covering diode, CO2, and Nd:YAG lasers, is limited by three main factors:
First, European dentists are still reluctant to make the initial investment in laser technology when traditional methods work just as well for their practice.
Second, although all tissue lasers are more expensive, they represent a viable alternative to soft tissue lasers with their wider range of applicability.
Third, the lack of government reimbursement for laser treatment by several European countries creates a significant disincentive for dentists to incorporate this technology into their daily workflow.
U.S. and European Competitors in the Dental Laser Market
In both Europe and the U.S., Biolase holds significant market presence, especially for articulated arm and fiber-delivered laser sales. Fotona leads in Europe, and still managed to make the top-10 in the United States. Other U.S. dental laser companies include AMD Lasers, Millennium Dental Technologies, Zila, Ivoclar Vivadent, Lutronic, and Sirona. Other European dental laser companies include KaVo, elexxion AG, Sirona, DEKA, A.R.C. Laser, and Oralia.
For Further Information
The series of reports on the dental lasers market covers the U.S. and 15 European countries. The full reports provide a comprehensive analysis including, units sold, market value, forecasts, as well as a detailed competitive market analysis of major players' success strategies in each market and segment.
Markets covered include: Soft tissues, dental welding, and all other dental tissues
Register or email us for a complimentary U.S. and European Dental Lasers Market - 2014 report synopsis.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/11/prweb12308592.htm